Abstract:Knowledge management (KM) is identified in ICH Q10 (Pharmaceutical Quality System), as a key enabler to the pharmaceutical quality system (PQS). ICH Q8 (Pharmaceutical Development), ICH Q11 (Development and Manufacture of Drug Substances), and ICH Q12 (Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management) each build on the expectation that knowledge will be managed effectively in order to support and improve the product and process across the pharmaceutical product life cycle. However, in spite of the fact that KM was introduced in ICH Q10 over 10 years ago, there is ample evidence that it is not yet a mature discipline within the biopharmaceutical sector, and the authors suggest that this could hinder full realization of the potential benefits of ICH Q8, ICH Q11, and ICH Q12. The Pharmaceutical Regulatory Science Team (PRST), a research team based at the Dublin Technological University (TU Dublin) in Ireland, has been conducting research on KM for several years, and this paper presents the next phase in this research. Specifically, the focus of this current research was to explore ways to offer practical solutions to improve the management of knowledge across the pharmaceutical product life cycle, starting with a focus on enhancing knowledge transfer during technology transfer projects. The typical challenges associated with ineffective knowledge transfer were presented and the high-level requirements needed to address these were identified through the research. From these requirements, a four-step framework was developed as a systematic means to enhance knowledge transfer. Accompanying the framework was a KM toolkit consisting of a range of KM practices (tools, processes, and behaviors) to facilitate more effective knowledge flow during technology transfer. It was then illustrated how such a framework can be extended across the entire pharmaceutical product life cycle, supporting the advancement of KM from an enabler in ICH Q10 to a key consideration (both technical and regulatory) in ICH Q12.

A Review on Life Cycle Management Approach on Asset Qualification

[The Traceability Management for Qualification Documents of Medical Instruments].

Quality By Design (QbD): A Comprehensive Understanding and Implementation In Pharmaceuticals Development

Knowledge Management as a Pharmaceutical Quality System Enabler: How Enhanced Knowledge Transfer Can Help Close the ICH Q10 to ICH Q12 Gap

Pharmaceutical product development: A quality by design (QbD) approach

Quality by Design Approach: Progress in Pharmaceutical method Development and Validation

Question-based review for pharmaceutical development: An enhanced quality approach

Quality by Design (QbD) in pharmaceutical development: A comprehensive review

Development and Qualification of a Scale-Down Mammalian Cell Culture Model and Application in Design Space Development by Definitive Screening Design

Quality by Design in Pharmaceuticals: A Review of its Impact on Regulatory Compliance and Product Quality

Validation of Sterile Water for Injection In Pharmaceutical Industry and Othersterile Facility

A Detailed Case Study on Deviation, Out-of-Specification(OOS) and CAPA Generation in Pharmaceutical Industry

A Practical Discussion of Risk Management for Manufacturing of Pharmaceutical Products

Multivariate Spectroscopic Method Lifecycle Management as Part of the Quality Management System

Quality by design (QbD) approaches in current pharmaceutical set-up

Process Validation in the Twenty-First Century

A BRIEF REVIEW ON PROCESS ANALYTICAL TECHNOLOGY (PAT)

Mastering Quality: Uniting Risk Assessment With Quality by Design (QbD) Principles for Pharmaceutical Excellence

Risk Assessment in the Calibration of Medical Equipment

Model-Based Methods in the Biopharmaceutical Process Lifecycle

A Review on Bioanalytical Method Development and Validation for Estimation of Drugs by Using Hyphenated Techniques and its Applications on Routine Analysis